Obesity
FDA to Evaluate Sandoz’s Generic Tirzepatide Candidates
As reported by Yahoo Finance, the U.S. Food and Drug Administration (FDA) has accepted for review two applications from Sandoz for generic versions of tirzepatide,
Clinical Trial to Evaluate Experimental Treatments Amid Expanding Bundibugyo Ebola Outbreak
- July 2, 2026
FDA Approves Viridian’s Lumvoa for Thyroid Eye Disease
Lilly Reports Phase 3 Success for Pirtobrutinib Combination in Relapsed CLL
UAE Launches First Genomics-Led Trial Aimed at Preventing Alzheimer’s Disease
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
Rare Disease
FDA Launches PreCheck Pilot to Accelerate U.S. Drug Manufacturing Capacity
As reported on FiercePharma, the U.S. Food and Drug Administration (FDA) has selected seven pharmaceutical and biotechnology companies to participate in its newly established PreCheck
Psoriasis
FDA Expands Approval of Roflumilast Cream (Zoryve) to Younger Children with Plaque Psoriasis
As reported on Healio, the U.S. Food and Drug Administration has broadened the indication for roflumilast cream 0.3% (Zoryve, Arcutis), allowing its use in children
Triple-negative breast cancer
“I Won’t Let This Define Me.”
Editor’s Note: Patient Worthy is honored to share this story from our friends at Elephants & Tea, originally written by Amy Hoffmann — a survivor
Dystonia
When Your Brain Won’t Quiet Down: A Look at Dystonia and Anxiety
One of the hardest things about living with dystonia is trying to explain what it feels like on the inside. People often see (not always for some) the muscle
COVID-19
The Future of Disease Understanding Starts with Listening
Editor’s Note: Patient Worthy is honored to share this article, provided by our friends at the TREND Community. To see the article in its original
Hidradenitis suppurativa
ICYMI: Make HStory Platform Offers Hidradenitis Suppurativa Education and Community Support
Editor’s Note: This article was originally published by Patient Worthy on 6/7/24, and is being republished due to our ongoing efforts to raise awareness of
Acromegaly
PATIENT INPUT NEEDED: Pituitary Adenoma vs. PitNET Nomenclature Change
Editor’s Note: This article is brought to you by our friends at the Acromegaly Community, and shared with our audience at their request. To learn
Dystonia
The Power of Our Inner Dialogue on Our Health
Editor’s Note: This article by Tom Seaman was originally shared by Patient Worthy on 12/15/22. I believe very strongly in the power of thoughts and
Rare Disease
Puberty Blocker Trial Aimed at Reducing Harm Amid Ongoing Debate in Youth Gender Care
A recent BBC report highlighted a forthcoming clinical trial examining puberty-suppressing medications in young people is being positioned by its proponents as a necessary step
Myelofibrosis
Lilly’s Type II JAK2 Inhibitor Shows Early Promise in Myelofibrosis
As reported on MedCity News, Eli Lilly has reported encouraging early-stage clinical data for AJ1-11095, an investigational therapy for myelofibrosis acquired through its recent purchase
Hypertrophic Cardiomyopathy
Les’ Journey with Cardiomyopathy
My name is Les Howard, and I am living with hypertrophic obstructive cardiomyopathy (HCM). Looking back, I believe I may have lived with HCM for most
Myelofibrosis
Sumitomo Pharma America Highlights Early Myelofibrosis and Leukemia Findings at EHA 2026
As reported on PharmaBiz, Sumitomo Pharma America (SMPA) presented new clinical and translational data spanning myelofibrosis (MF) and acute leukemia programs at the 2026 European
Colorectal cancer
A Colonoscopy Remains the Gold Standard to Detect Colorectal Cancer
In the United States, colorectal cancer represents the third most frequently diagnosed malignancy and the second leading cause of cancer-related death. A colonoscopy continues to
Fibrinogen deficiency
Grifols Launches New Bleeding Disorder Treatment, FESILTY™, in the U.S.
Grifols, as announced in a recent press release, has officially launched FESILTY™ (fibrinogen, human-chmt) in the United States. The therapy is approved to treat sudden,
Diabetes Type 1
First Disease-Modifying Therapy to Delay Type 1 Diabetes Now Available Through NHS
As reported by the BBC, landmark advance in type 1 diabetes care has been reached with the introduction of teplizumab, the first treatment shown to
Ebola
An Update on the Ebola Outbreak
Further to the WHO’s official confirmation of an outbreak of 300 Ebola cases as of May 2026, health authorities in the Democratic Republic of the
Rare Disease
Breathing Easier: A New Weapon in the Battle Against Deadly Lung Molds
Every single day, the average person inhales thousands of microscopic fungal spores. For most of us, our immune systems destroy these tiny invaders before they
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
our friends @CureMito🚨 Exciting Opportunity for US residents only (at this time)! 🚨 We're seeking volunteers for our gut microbiome study at Icahn School of Medicine. If your child ages 1+ with SURF1, ECHS1 or MT-ATP6 Leigh syndrome can participate, we need you! 🧬
🔎 Study involves sharing medical records, optional diet logging, and sending stool samples (we cover shipping).
Ideal healthy volunteers are close in age to the affected child. Siblings or parents can join too. Interested? Reach out for more info! 🌟
🚨 Exciting Opportunity for US residents only (at this time)! 🚨 We're seeking volunteers for our gut microbiome study at Icahn School of Medicine. If your child ages 1+ with SURF1, ECHS1 or MT-ATP6 Leigh syndrome can participate, we need you! 🧬
🔎 Study involves sharing medical records, optional diet logging, and sending stool samples (we cover shipping).
Ideal healthy volunteers are close in age to the affected child. Siblings or parents can join too. Interested? Reach out for more info! 🌟
This content isn't available right now
When this happens, it's usually because the owner only shared it with a small group of people, changed who can see it or it's been deleted.
